Published in J Diabetes Complications on July 24, 2010
A Practical Approach to Glucose Abnormalities in Cystic Fibrosis. Diabetes Ther (2016) 0.75
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med (2005) 10.16
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet (2009) 7.24
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial. Lancet (2010) 4.89
Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature (2012) 3.41
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation (2007) 3.01
Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology (2013) 2.84
Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial. Eur Heart J (2007) 2.56
The prevalence, anatomical correlates and treatment of sleep-disordered breathing in obese children and adolescents. Sleep Med Rev (2008) 2.33
Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care (2006) 2.18
Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism (2006) 2.14
Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia. Arterioscler Thromb Vasc Biol (2010) 2.03
Variants in the FTO gene are associated with common obesity in the Belgian population. Mol Genet Metab (2007) 1.82
Sleep-disordered breathing in overweight and obese children and adolescents: prevalence, characteristics and the role of fat distribution. Arch Dis Child (2006) 1.67
The importance of the development of the intestinal microbiota in infancy. Curr Opin Pediatr (2009) 1.59
Prevalence of loss-of-function FTO mutations in lean and obese individuals. Diabetes (2009) 1.54
C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients. J Hepatol (2011) 1.54
Intrauterine exposure to environmental pollutants and body mass index during the first 3 years of life. Environ Health Perspect (2008) 1.44
The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One (2013) 1.22
Obesity and persistent organic pollutants: possible obesogenic effect of organochlorine pesticides and polychlorinated biphenyls. Obesity (Silver Spring) (2010) 1.19
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects. Eur J Endocrinol (2009) 1.19
Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations. Pituitary (2014) 1.16
Effect of long-term whole body vibration training on visceral adipose tissue: a preliminary report. Obes Facts (2010) 1.14
Flow mediated dilatation and cardiac function in type 1 diabetes mellitus. Am J Cardiol (2005) 1.13
Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age. Diabetes Care (2011) 1.12
Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity. Diabetes (2011) 1.12
Safety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeks. Diabetes Care (2012) 1.04
Organochlorine and heavy metals in newborns: results from the Flemish Environment and Health Survey (FLEHS 2002-2006). Environ Int (2009) 1.01
Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status. Diabetes Metab Res Rev (2006) 0.99
Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. PLoS One (2013) 0.97
Glucose control and use of continuous glucose monitoring in the intensive care unit: a critical review. Curr Diabetes Rev (2008) 0.97
Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial. Metabolism (2009) 0.97
Loss-of-function mutations in SIM1 contribute to obesity and Prader-Willi-like features. J Clin Invest (2013) 0.96
Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids. Diabetologia (2013) 0.95
Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. Diabetes Technol Ther (2013) 0.94
Sleep-disordered breathing and uric acid in overweight and obese children and adolescents. Chest (2007) 0.94
Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. Clin Gastroenterol Hepatol (2012) 0.94
Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel. Curr Med Res Opin (2005) 0.91
The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men. Endocrine (2007) 0.91
Efficacy and safety of the weight-loss drug rimonabant. Lancet (2008) 0.91
Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitus. PLoS One (2012) 0.90
The effect of weight loss on sleep-disordered breathing in obese teenagers. Obesity (Silver Spring) (2009) 0.90
The effect of whole body vibration short-term exercises on respiratory gas exchange in overweight and obese women. Phys Sportsmed (2009) 0.89
A review of current evidence with continuous glucose monitoring in patients with diabetes. J Diabetes Sci Technol (2008) 0.89
Association of the BDNF Val66Met variation with obesity in women. Mol Genet Metab (2008) 0.88
Minimally-invasive and non-invasive continuous glucose monitoring systems: indications, advantages, limitations and clinical aspects. Curr Diabetes Rev (2008) 0.88
A longitudinal analysis on the association between antibiotic use, intestinal microflora, and wheezing during the first year of life. J Asthma (2008) 0.88
Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study. Pituitary (2014) 0.87
Dynamics of organohalogenated contaminants in human serum from obese individuals during one year of weight loss treatment. Environ Sci Technol (2013) 0.87
Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results. J Hypertens (2008) 0.87
Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients. BMC Microbiol (2010) 0.87
Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care (2015) 0.86
Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease. Cytokine (2012) 0.86
Iron-binding antioxidant capacity is impaired in diabetes mellitus. Free Radic Biol Med (2006) 0.86
Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1dm). Magnes Res (2004) 0.86
Sleep-disordered breathing and C-reactive protein in obese children and adolescents. Sleep Breath (2013) 0.85
Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial. Pituitary (2015) 0.85
Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis. Eur J Gastroenterol Hepatol (2010) 0.83
Overweight in adolescents: differences per type of education. Does one size fit all? J Nutr Educ Behav (2008) 0.83
An unusual case of traumatic pneumatocele in a nine-year-old girl: a bronchial tear with clear bronchial laceration. Pediatr Pulmonol (2009) 0.83
Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device. Diabetes Metab Res Rev (2004) 0.83
Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT. J Pediatr Gastroenterol Nutr (2011) 0.83
Plasma adiponectin level is inversely correlated with albuminuria in overweight and obese nondiabetic individuals. Metabolism (2013) 0.83
Is breast feeding a risk factor for eczema during the first year of life? Pediatr Allergy Immunol (2007) 0.82
Screening for cannabis use in a pediatric sleep clinic. J Paediatr Child Health (2008) 0.82
Impact of waist circumference difference on health-care cost among overweight and obese subjects: the PROCEED cohort. Value Health (2010) 0.82
Magnesium loss in cyclosporine-treated patients is related to renal epidermal growth factor downregulation. Nephrol Dial Transplant (2013) 0.80
Early response to sibutramine in patients not meeting current label criteria: preliminary analysis of SCOUT lead-in period. Obesity (Silver Spring) (2009) 0.80
Relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthood. J Clin Endocrinol Metab (2002) 0.80
Possible role for ENPP1 polymorphism in obesity but not for INSIG2 and PLIN variants. Endocrine (2009) 0.80
Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients? Eur J Pediatr (2006) 0.79
The Belgian Diabetes in Pregnancy Study (BEDIP-N), a multi-centric prospective cohort study on screening for diabetes in pregnancy and gestational diabetes: methodology and design. BMC Pregnancy Childbirth (2014) 0.79
Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin. Atherosclerosis (2004) 0.78
Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients. J Clin Endocrinol Metab (2014) 0.78
Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates. Acta Cardiol (2008) 0.78
Coenzyme Q as an antiadipogenic factor. Antioxid Redox Signal (2010) 0.78
Non-invasive biomarker sampling and analysis of the exhaled breath proteome. Proteomics Clin Appl (2009) 0.78
Minimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients. Diabetes Care (2013) 0.76
Obesity in Europe - does anybody care? Expert Opin Pharmacother (2013) 0.76
Phthalate metabolites in obese individuals undergoing weight loss: Urinary levels and estimation of the phthalates daily intake. Environ Int (2013) 0.76
Prolonged flare-up of testosterone after administration of a gonadotrophin agonist to a sex offender: an under-recognised risk? Crim Behav Ment Health (2015) 0.76
LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial. J Hypertens (2016) 0.76
Metabolic syndrome in youth: a cross-sectional school-based survey. Acta Paediatr (2007) 0.76
Fractional order model parameters for the respiratory input impedance in healthy and in asthmatic children. Comput Methods Programs Biomed (2010) 0.76
Sleep duration and insulin resistance in obese children: when variables are sleeping too close together. J Pediatr (2007) 0.75
Lixisenatide treatment for older patients with type 2 diabetes mellitus uncontrolled on oral antidiabetics: meta-analysis of five randomized controlled trials. Adv Ther (2014) 0.75
Upper airway lymphoid tissues in obese children with sleep apnea: clinical implications. Am J Respir Crit Care Med (2011) 0.75
Adenotonsillectomy as first-line treatment for sleep-disordered breathing in obese children. Am J Respir Crit Care Med (2008) 0.75
High incidence of the CFTR mutations 3272-26A-->G and L927P in Belgian cystic fibrosis patients, and identification of three new CFTR mutations (186-2A-->G, E588V, and 1671insTATCA). J Cyst Fibros (2007) 0.75
The Effect of Lifestyle Interventions on Excess Ectopic Fat Deposition Measured by Noninvasive Techniques in Overweight and Obese Adults: A Systematic Review and Meta-Analysis. J Phys Act Health (2015) 0.75
Pharmacologic treatment of obesity. J Obes (2012) 0.75
Relation between weight loss and causes of death in patients with cardiovascular disease: finding from the SCOUT trial. J Cardiovasc Med (Hagerstown) (2017) 0.75
Translating continuous glucose monitoring systems: toys or tools. Curr Diabetes Rev (2008) 0.75
Correction: Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio. PLoS One (2017) 0.75
Age and early graft function relate with risk-benefit ratio of allogenic islet transplantation under Anti-thymocyte globulin - Mycophenolate mofetil - Tacrolimus immune suppression. Transplantation (2016) 0.75